Tom reports and edits European consumer health care industry news and analysis. Leading HBW Insight’s health and wellness coverage in Europe, he has been writing about the sector since 2013. Tom’s main focus is analyzing the strategies of the world's leading consumer healthcare companies, their business performance, plans and product portfolios. He also reports on regulatory topics such as novel foods and prescription-to-OTC switches.
Latest from Tom Gallen
The Swedish firm is plotting the path towards launching its ColdZyme virus-blocking spray in China and Japan, while efforts are also underway to find a partner for the North American market.
Venture capital fund backed by Germany's Schwabe has €100m to invest in consumer health startups operating in categories such as sleep and mental health.
Demand returns for Nestle's US dietary supplement brands following supply chain issues, helping the firm's Health Science division post a solid uplift in sales for 2024.
As Norway's Orkla Health searches for a new CEO, the business looks well-placed for future growth after a 15% uplift in sales in 2024.
Navamedic is seeing good early sales for OTC ED treatment Eroxon in multiple Nordic markets after investing in a marketing push which includes a Mission Impossible-inspired commercial.
Biotech identifying and stabilizing RNA compounds that can be incorporated into dietary supplements will receive mentorship, strategy guidance and technical support from experts at Nestlé Health Science.